Mellion Michelle L
SEC CIK 1923040 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PEPG | PepGen Inc. | SVP, Clinical Development | 201 | — | $905.6K | 14 | 2024-06-05 | 2024-07-24 |
Most active insiders at PEPG, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RA Capital Healthcare Fund LP | Dir, 10% | $30.00M | — |
| 2 | Oxford Science Enterprises plc | Former 10% Owner | $640.0K | — |
| 3 | McArthur James G | Pres, CEO, Dir | — | $32.9K |
| 4 | Donnelly Noel | CFO | — | $13.0K |
| 5 | STRECK PAUL | EVP, Head of R, D | — | $11.7K |
| 6 | Kasraian Kasra | Chief Technical Off | — | $1,739 |
| 7 | Vittiglio Joseph | Chief Business, Legal Off | — | — |
Mellion Michelle L made no open-market trades at PEPG in the last 12 months.
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-07-26 | 2024-07-24+ | PEPG | PepGen Inc. | Mellion Michelle L | Chief Medical Off | M - OptEx | $10.21 | +7,772 | 201 | New | +$79.4K |
| DM | 2024-07-26 | 2024-07-24+ | PEPG | PepGen Inc. | Mellion Michelle L | Chief Medical Off | S - Sale+OE | $18.06 | -7,772 | 0 | -100% | -$140.4K |
| D | 2024-07-19 | 2024-07-18 | PEPG | PepGen Inc. | Mellion Michelle L | Chief Medical Off | S - Sale+OE | $18.20 | -12.6K | 0 | -100% | -$229.8K |
| D | 2024-07-19 | 2024-07-18 | PEPG | PepGen Inc. | Mellion Michelle L | Chief Medical Off | M - OptEx | $10.21 | +12.6K | 12.6K | New | +$128.9K |
| DM | 2024-07-16 | 2024-07-12+ | PEPG | PepGen Inc. | Mellion Michelle L | Chief Medical Off | M - OptEx | $10.21 | +9,189 | 3,288 | New | +$93.8K |
| DM | 2024-07-16 | 2024-07-12+ | PEPG | PepGen Inc. | Mellion Michelle L | Chief Medical Off | S - Sale+OE | $18.01 | -9,189 | 0 | -100% | -$165.5K |
| DM | 2024-07-03 | 2024-07-01+ | PEPG | PepGen Inc. | Mellion Michelle L | Chief Medical Off | S - Sale+OE | $18.01 | -912 | 0 | -100% | -$16.4K |
| DM | 2024-07-03 | 2024-07-01+ | PEPG | PepGen Inc. | Mellion Michelle L | Chief Medical Off | M - OptEx | $10.21 | +912 | 875 | New | +$9,312 |
| D | 2024-06-26 | 2024-06-24 | PEPG | PepGen Inc. | Mellion Michelle L | Chief Medical Off | S - Sale+OE | $18.19 | -9,260 | 0 | -100% | -$168.4K |
| D | 2024-06-26 | 2024-06-24 | PEPG | PepGen Inc. | Mellion Michelle L | Chief Medical Off | M - OptEx | $10.21 | +9,260 | 9,260 | New | +$94.5K |
| DM | 2024-06-13 | 2024-06-11+ | PEPG | PepGen Inc. | Mellion Michelle L | Chief Medical Off | S - Sale+OE | $18.05 | -1,586 | 0 | -100% | -$28.6K |
| DM | 2024-06-13 | 2024-06-11+ | PEPG | PepGen Inc. | Mellion Michelle L | Chief Medical Off | M - OptEx | $10.21 | +1,586 | 1,086 | New | +$16.2K |
| DM | 2024-06-07 | 2024-06-05+ | PEPG | PepGen Inc. | Mellion Michelle L | SVP, Clinical Development | M - OptEx | $10.21 | +8,656 | 7,245 | New | +$88.4K |
| DM | 2024-06-07 | 2024-06-05+ | PEPG | PepGen Inc. | Mellion Michelle L | SVP, Clinical Development | S - Sale+OE | $18.08 | -8,656 | 0 | -100% | -$156.5K |
Purchase Sale Sale after option exercise All abbreviations